- The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype(2020)
Authors: Niels Vandamme, Geertrui Denecker, Kenneth Bruneel, Ozden Akay, Joachim Taminau, Eva De Smedt, Nicolas Skrypek, Wouter Van Loocke, Jasper Wouters, David Nittner, et al.
Pages: 2983 - 2995
- ZEB1 as 'jack-of-all-trades' in breast cancer progression(2019)
Authors: Eva De Smedt
- ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition(2018)
Authors: Nicolas Skrypek, Kenneth Bruneel, Cindy Vandewalle, Eva De Smedt, Bieke Soen, Nele Loret, Joachim Taminau, Steven Goossens, Niels Vandamme, Geert Berx
- Epithelial-to-mesenchymal transition : epigenetic reprogramming driving cellular plasticity(2017)
Authors: Nicolas Skrypek, Eva De Smedt, Niels Vandamme
Pages: 943 - 959
- Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research(2017)
Authors: Glenn Vergauwen, Jan Van Deun, Eva De Smedt, Evy Timmerman, Ilkka Miinalainen, Veronique Cocquyt, Rudy Van den Broecke, Hannelore Denys, An Hendrix